BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12642697)

  • 41. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis.
    Nelson V; Davis GE; Maxwell SA
    Apoptosis; 2001 Jun; 6(3):221-34. PubMed ID: 11388671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation.
    Zhang Y; Xiong Y
    Science; 2001 Jun; 292(5523):1910-5. PubMed ID: 11397945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy.
    Chène P
    Nat Rev Cancer; 2003 Feb; 3(2):102-9. PubMed ID: 12563309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
    Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
    Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.
    Sionov RV; Coen S; Goldberg Z; Berger M; Bercovich B; Ben-Neriah Y; Ciechanover A; Haupt Y
    Mol Cell Biol; 2001 Sep; 21(17):5869-78. PubMed ID: 11486026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling.
    Fusaro G; Dasgupta P; Rastogi S; Joshi B; Chellappan S
    J Biol Chem; 2003 Nov; 278(48):47853-61. PubMed ID: 14500729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis.
    Townsend PA; Scarabelli TM; Davidson SM; Knight RA; Latchman DS; Stephanou A
    J Biol Chem; 2004 Feb; 279(7):5811-20. PubMed ID: 14602726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.
    Ard PG; Chatterjee C; Kunjibettu S; Adside LR; Gralinski LE; McMahon SB
    Mol Cell Biol; 2002 Aug; 22(16):5650-61. PubMed ID: 12138177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear accumulation of p53 following inhibition of transcription is not due to diminished levels of MDM2.
    O'Hagan HM; Ljungman M
    Oncogene; 2004 Jul; 23(32):5505-12. PubMed ID: 15094782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
    Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
    J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
    Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
    Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor.
    Girnita L; Girnita A; Larsson O
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8247-52. PubMed ID: 12821780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.
    Tao W; Levine AJ
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3077-80. PubMed ID: 10077639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitric oxide induces phosphorylation of p53 and impairs nuclear export.
    Schneiderhan N; Budde A; Zhang Y; Brüne B
    Oncogene; 2003 May; 22(19):2857-68. PubMed ID: 12771937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of p53 localization.
    Liang SH; Clarke MF
    Eur J Biochem; 2001 May; 268(10):2779-83. PubMed ID: 11358492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress.
    Lee JH; Jeong MW; Kim W; Choi YH; Kim KT
    J Biol Chem; 2008 Jul; 283(28):19826-35. PubMed ID: 18490454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells.
    Rodriguez-Lopez AM; Xenaki D; Eden TO; Hickman JA; Chresta CM
    Mol Pharmacol; 2001 Jan; 59(1):135-43. PubMed ID: 11125034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The p53-Mdm2 module and the ubiquitin system.
    Michael D; Oren M
    Semin Cancer Biol; 2003 Feb; 13(1):49-58. PubMed ID: 12507556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.